EN DE
Your region: EU (without Germany)

Your region: EU (without Germany)
Shop By

Filter by:

  1. Remove This Item Origin of cells: breast
  2. Remove This Item Product: K2 Transfection System
Clear All

Filter

Reference type
  1. application note (5)
  2. publication (26)
Species
  1. Human (26)
  2. Mouse (4)
Common cell type
  1. cell line (30)
  2. primary cell (1)
Nucleic acid / Delivered molecule
  1. plasmid (22)
  2. siRNA (3)
  3. miRNA (6)
Application
  1. stable transfection (2)
  2. RNA-Interference (3)

References

Set Ascending Direction

1-25 of 31

Page:
  1. 1
  2. 2

Products Transfection
Free Sample Offer

Instruction for Use:

In the „Transfection Reagent Selection Guide“ you can find existing references by setting different filters e.g. for your combination of nucleic acid and cell type. Appropriate keywords in the “Search references“ at the top of the page can also yield a result. A reference indicates that the found transfection reagent has been successfully used for the corresponding application. Ideally, tested transfection parameters and transfection efficiencies are specified.

No reference? > General Selection Guide

If the list does not include a reference concerning your cell type, this does not mean that there is no suitable reagent available, but only that there is no report of experiences with this cell type. In this case it is necessary to preselect (General Selection Guide) and test a reagent (Free Sample Offer). If you want to write an application note for us we will make you an Offer for consideration.



CELL TYPE DESCRIPTION OF CELL TYPE CAT.NO. SPECIES ORIGIN OF CELLS COMMON CELL TYPE GROWTH PROPERTIES NUCLEIC ACID / DELIVERED MOLECULE APPLICATION PRODUCT REFERENCE TYPE BIBLIOGRAPHIC DATA PDF LINK

TAM6

 Human breast adenocarcinoma cell line (MCF-7 clone) Human breast cell line adherent miRNA K2 Transfection System publication B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 Link

TAM6

 Human breast adenocarcinoma cell line (MCF-7 clone) Human breast cell line adherent plasmid K2 Transfection System publication B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 Link

T-47D

 Human breast cancer cel line ATCC HTB-133 Human breast cell line adherent miRNA K2 Transfection System publication B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 Link

T-47D

 Human breast cancer cel line ATCC HTB-133 Human breast cell line adherent plasmid K2 Transfection System publication B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 Link

MDA-MB-231

 Human breast adenocarcinoma cell line ATCC HTB-26 Human breast cell line adherent plasmid K2 Transfection System publication J. Arnold, et al., Journal of Experimental & Clinical Cancer Research, 2020, 39: 205, doi.org/10.1186/s13046-020-01712-w Link

MDA-MB-231

 Human breast adenocarcinoma cell line ATCC HTB-26 Human breast cell line adherent plasmid K2 Transfection System application note

MDA-MB-231

 Human breast adenocarcinoma cell line ATCC HTB-26 Human breast cell line adherent plasmid K2 Transfection System publication Y.-F. Chuang et al., British Journal of Pharmacology, 2017, 174: 2941-2961

MCF7

 Human breast fibrocystic disease cell line ATCC HTB-22 Human breast cell line adherent plasmid stable transfection K2 Transfection System publication B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference K2 Transfection System publication B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System application note

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication A. Hermawan, Ludwig-Maximilians-Universität München Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent miRNA K2 Transfection System publication B. Ljepoja et al., Breast, 2019, 43, 31e38, https://doi.org/10.1016/j.breast.2018.10.007 Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System application note

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid stable transfection K2 Transfection System publication B. Ljepoja et al., Scientific Reports, 2018, 8:6927, DOI:10.1038/s41598-018-25240-y Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent miRNA K2 Transfection System publication B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication V. Morales-Garcia et al., FEBS Open Bio 10, 2020, 2541–2552, doi:10.1002/2211-5463.12987

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication A.-K. Sommer et al., Oncotarget, 2016, 7 (31): 50461 Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication B. Ljepoja et al., PLoS ONE, 2019, 14(11): e0224314, doi.org/10.1371/journal.pone.0224314 Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication B. Ljepoja et al., Breast, 2019, 43, 31e38, https://doi.org/10.1016/j.breast.2018.10.007 Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference K2 Transfection System application note

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent miRNA K2 Transfection System publication B. Ljepoja et al.,The Breast, 2019, 43: 31-38, doi.org/10.1016/j.breast.2018.10.007 Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent siRNA RNA-Interference K2 Transfection System publication B. Ljepoja et al., PLoS ONE, 2019, 14(11): e0224314, doi.org/10.1371/journal.pone.0224314 Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication B. Ljepoja, Dissertation, 2019, Ludwig-Maximilians-Universität München Link

MCF-7

 Human breast adenocarcinoma cell line ATCC HTB-22 Human breast cell line adherent plasmid K2 Transfection System publication C. Actis et al., Cancers, 2021, 13: 1252, doi.org/10.3390/cancers13061252 Link

Set Ascending Direction

1-25 of 31

Page:
  1. 1
  2. 2

Fax-order

Feel free to order by fax:
0049 89 32479952
Europe
0049 89 32479952
USA/Canada
01149 89 32479952
Australia
001149 89 32479952

Email-order

Feel free to order via email: order@biontex.com

Online-order

To view the correct product and freight prices, please select your region.

By continuing to browse this website, you agree to the use of cookies. Read more
© 2016 Biontex Laboratories GmbH. All rights reserved.